MS patients in Wales can face up to six-hour round trips for specialist care, new report shows
- Some people living with MS can face up to 6-hour round trips for specialist care, with treatment decisions often influenced by travel constraints rather than clinical need[1]
- MS nurse patient caseloads average around 30% above the recommended sustainable level[2]
- Compared to the rest of Wales, the north has the lowest MS consultant availability, the highest MS specialist nurse patient caseloads and the lowest access to the most effective treatments for new patients[3]
- Patients face waits of over 12 months for neuropsychology support, with only one specialist in Wales – and charities and local services are struggling to plug the mental health gap[4]
Ahead of World MS Day 2026 (30th May), MS Society Cymru and Merck, a leading science and technology company, have published a report analysing multiple sclerosis (MS) services and workforce levels across Wales. Developed in collaboration with Professor Neil Robertson (Cardiff University) and leading neurology clinicians across Wales’ seven health boards, the report highlights growing pressure on services and variation in access to care.
The report, ‘Mapping and analysis of the multiple sclerosis workforce in Wales (May 2026)’, was initiated, organised and funded by Merck and developed in collaboration with Professor Robertson, MS Society Cymru, and MS clinical teams across Welsh and English providers where services are delivered cross‑border. It provides the first national mapping of MS workforce and service provision across Wales’ seven health boards benchmarked against national recommendations and guidance on minimum service standards for people living with MS.
It highlights how geography, workforce capacity and service configuration are all negatively shaping patients’ experiences. In response, MS Society Cymru is calling for urgent action to ensure everyone living with MS can access consistent, timely support closer to home.
MS is a lifelong condition that affects nerves in the central nervous system which can cause a range of symptoms such as blurred vision and problems with movement. It affects over 6,900 people in Wales with its prevalence having risen by 13% since 2019[5].
The report’s topline findings include:
Inequalities in MS services across Wales
The Welsh Index of Multiple Deprivation shows the most deprived fifth of localities are in post-industrial communities in South Wales and certain coastal areas[6]. With this deprivation in mind, the report highlights differences from north to south and east to west:
North Wales
- Compared to the rest of Wales has the lowest consultant access (0.8 working time equivalent (WTE) or one full-time MS healthcare professional per 1,000 MS patients), and the highest MS nurse patient caseloads (501 patients per WTE nurse)[7], risking longer waits and reduced capacity for optimal care.
- There are disparities in access to treatment; in some areas over 70% of newly diagnosed patients have access to higher-efficacy disease modifying treatments (higher-efficacy therapies are considered as those with over 50% reduction (or otherwise significant reduction) in relapse rate compared to a placebo or comparator), while in others this falls as low as 16%[8].
- Travel remains a barrier to accessing care, with some patients – particularly those in rural areas – facing up to 6-hour round trips for specialist care, with treatment decisions often influenced by travel constraints rather than clinical need[9].
Mid‑Wales
- People with MS in this area often have their care split across multiple Welsh and English providers making coordination, accountability, and safety monitoring harder to achieve[10].
MS workforce challenges across Wales
The report reveals a succession planning gap with seven consultant neurologists and eight MS nurses across Wales approaching retirement in the next five years and a limited replacement pipeline. These concerns compound an already stretched workforce with the report finding that there are only 11.1 WTE consultant neurologists with a specialist interest in MS and 16.2 WTE MS nurses responsible for a reported caseload of 6,643 MS patients[11]. The findings also identified:
- MS nurse patient caseloads average 410 MS patients per WTE nurse – 30% above the recommended sustainable level of 315.[12]
- No Advanced MS Champions (specialist nurses or therapists who help coordinate care to improve a patient’s quality of life) are deployed across Wales, despite pilot data showing that use of an Advanced MS Champion reduced the need for around 52 hospital admissions, 115 general practice (GP) appointments and 91 specialist MS nurse appointments annually across each pilot site[13].
Barriers to mental health support or care at home
Living with MS can impact on mental health, with depression rates being 2-3 times higher in people with MS in comparison to the general population[14]. Despite this, only patients in Cardiff & Vale and Cwm Taf have access to MS-specific neuropsychologists. Even where there are general or specialist neuropsychologist services, investigators reported waiting lists can exceed 12 months. As a result, almost all those with MS in Wales have difficulty accessing MS-specific psychological support[15]. Limited transport infrastructure, as above, further compounds these challenges.
Many MS patients experience mobility limitations and are not able to drive[16]. With limited public transport in some rural areas of Wales getting to appointments can be difficult. The report found that only three health boards had a functioning home visit service[17]. It also identified that some patients changed their treatment options due to the longer travel times they faced, rather than choosing treatment based on their individual medical need[18].
A call for coordinated, equitable solutions
MS Society Cymru and the report authors are calling for urgent action to ensure people with MS in Wales can access equitable, sustainable care. Their recommendations include strengthening specialist MS services in mid‑Wales and a better resourced specialist centre in North Wales.
Shelley Elgin, Director for Wales, MS Society, said:
“MS can be debilitating, exhausting and unpredictable. People with MS in Wales should not have to plan their health around geography, yet this report shows some patients face up to a six‑hour round trip just to access the care they need.
Right now, the neurology workforce in Wales is overstretched and the lack of succession planning is a ticking time bomb. We also have huge concerns about the lack of MS-specific psychological support and home visit services, which are leaving people with MS feeling isolated and unsupported. We need urgent, coordinated action to address these inequalities, support the Welsh MS community, and tackle this crisis now.”
Dr Doina Ionescu, General Manager UK & Ireland, Merck, said:
“Merck is committed to supporting the MS community across Wales, and to working with clinicians and patient organisations to help drive high equitable standards of service. By bringing together the evidence in this report, we hope it helps inform practical workforce and service planning so that more people can access coordinated MS care closer to home.”
Professor Neil Robertson, Professor of Clinical Neurology, Cardiff University, said:
“As a neurologist, I have seen how dramatically MS care has advanced in the last two decades — but I have also seen how uneven access can be to specialist services, and how workforce constraints and geography can get in the way of the care people need. This mapping paper gives Wales a clear blueprint: where services are strong, where the gaps are, and how we can work together to build a more equitable, sustainable MS service for patients and families. It offers a unique opportunity to work together for an interactive network, developing integrated services for people with MS across Wales.”
Jacki Smee, MS Nurse Specialist, Cardiff and Vale University Health Board, said:
“MS nurses play a vital role in delivering specialist care, treatment and education for people with MS. Increasingly complex treatment decision making requires a multi-disciplinary approach with MS nurses coordinating much of this care. The report highlights that many MS nurses across Wales are due to retire in the next 2-5 years (or have partially retired already). Succession planning and training new nurses will be key to the delivery of MS services fit for future.”
Helen Owen, MS Nurse Specialist, Swansea Bay University Health Board, said:
“As an MS nurse I am involved in supporting people with MS and their families in all aspects of their care. There have been rapid advancements in treatment and there are new treatments on the horizon. Whilst this is an exciting time in the field of MS, it is also challenging for services to be able to deliver and provide safe and effective monitoring of these treatments. This report highlights the increasing areas of need that all MS services in Wales are facing and gives the foundation on which services can develop their workforce and innovate to provide an equitable service throughout Wales.”
Stuart Nixon, MBE, MS Society Ambassador living with MS:
“This excellent report demonstrates, in stark terms, the precarious state of MS services across Wales. With consultant numbers half that of the UK as a whole, and MS nurses with a 1/3 more patients than other nations, access to medical specialists is poor. Given the present lack of adequate succession planning, this situation could become catastrophic very soon. MS services in Wales need help now to avoid this!”
The full list of recommendations – including on new specialist centres, workforce planning and better digital processes – as well as details on the report methodology can be found can be found in the report published on the MS Society Cymru website – https://www.mssociety.org.uk/mapping-ms-services-wales .
[1] MS Society Cymru and Merck Serono Ltd et al, 2026, p29. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[2] MS Society Cymru and Merck Serono Ltd et al, 2026, p5. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[3] MS Society Cymru and Merck Serono Ltd et al, 2026, p5. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[4] MS Society Cymru and Merck Serono Ltd et al, 2026, p5. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[5] MS Trust, (2024), ‘Number of people living with MS in the UK increases’.
[6] Welsh Government, (2024), ‘Welsh Index of Multiple Deprivation (WIMD) 2023-24’. Available at https://www.gov.wales/welsh-index-multiple-deprivation-2025-series [Accessed May 2026].
[7] MS Society Cymru and Merck Serono Ltd et al, 2026, p5. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[8] MS Society Cymru and Merck Serono Ltd et al, 2026, p6. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[9] MS Society Cymru and Merck Serono Ltd et al, 2026, p29. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[10] MS Society Cymru and Merck Serono Ltd et al, 2026, p5. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[11] MS Society Cymru and Merck Serono Ltd et al, 2026, p13. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[12] MS Society Cymru and Merck Serono Ltd et al, 2026, p13. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[13] MS Society Cymru and Merck Serono Ltd et al, 2026, p16. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[14] Boeschoten, R. E., et al. (2022). “Prevalence of depression and anxiety in multiple sclerosis: A systematic review and meta-analysis.” Journal of the Neurological Sciences, 372, 331-341.
[15] MS Society Cymru and Merck Serono Ltd et al, 2026, p15. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[16] MS Society, 2016, ‘Motoring with multiple sclerosis’. Available at https://www.mssociety.org.uk/sites/default/files/2020-10/Motoring-with-MS-April-2016.pdf [Accessed May 2026]
[17] MS Society Cymru and Merck Serono Ltd et al, 2026, p17. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]
[18] MS Society Cymru and Merck Serono Ltd et al, 2026, p17. ‘Mapping and analysis of the multiple sclerosis workforce in Wales’. Available at https://www.mssociety.org.uk/mapping-ms-services-wales [Accessed May 2026]